See also this year's filing and all EDGAR filings for this company.
PDF Report 0000792977_2015_AMAG_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0000792977, AMAG Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 274,036,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,093,732,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,519,000 |
| 3 | remainder_Assets | 19,646,000 |
| 4 | LiabilitiesCurrent | 166,488,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 762,492,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 70,684,835 |
| 9 | ResearchAndDevelopmentExpense | 24,563,791 |
| 10 | remainder_Expenses | 26,873,213 |
| 11 | remainder_Revenues | 118,672,857 |
| 12 | remainder_NetIncome | 1,351,473 |
| 13 | remainder_ComprehensiveNetIncome | -244,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,388,933,000 |
| 1 | Liabilities | 928,980,000 |
| 2 | Expenses | 122,121,839 |
| 3 | Revenues | 118,672,857 |
| 4 | StockholdersEquity | 459,953,000 |
| 5 | NetIncome | -2,097,509 |
| 6 | ComprehensiveNetIncome | -2,219,509 |
| 7 | BaseVar | 1,280,151,584 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.863 |
| 9 | EconomicCapitalRatio | 2.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
